Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Decreases By 56.6%

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 11,800 shares, a decrease of 56.6% from the September 30th total of 27,200 shares. Based on an average trading volume of 74,700 shares, the days-to-cover ratio is presently 0.2 days.

Sysmex Price Performance

Shares of Sysmex stock traded down $0.11 during midday trading on Friday, hitting $18.46. 116,970 shares of the company traded hands, compared to its average volume of 108,919. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.40 and a current ratio of 3.23. The stock has a market cap of $11.62 billion, a price-to-earnings ratio of 36.87 and a beta of 0.83. Sysmex has a 12 month low of $14.38 and a 12 month high of $29.78. The firm's fifty day moving average price is $19.28 and its 200-day moving average price is $17.43.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.11 earnings per share (EPS) for the quarter. The company had revenue of $718.13 million for the quarter. As a group, sell-side analysts forecast that Sysmex will post 0.65 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.